Organ and Tissue Transplantation and Alternatives: HLC012F

Library

Username

Password

Remember Me

Forgot password/Login issues?

Not a Member? Learn more.

Report Highlights

The global market for organ and tissue transplantation products and devices reached $56.9 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 7.1% to reach $64.4 billion by 2015 and nearly $90.6 billion by 2020.

Report Includes

An overview of the global markets for organ and tissue transplantation and alternatives.
Analyses of global market trends, with data from 2014, estimates for 2015 and projections of CAGR through 2020.
Detailed examination of procurement and preservation, solid organ transplantation, tissue transplantation, immunosuppressives and other pharmaceuticals, post-transplantation concerns, as well as alternatives to transplantation.
Coverage of post-transplant immunosuppression and monitoring methods and post-transplant drug regimens and patient and graft survival rates.
In-depth analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
Comprehensive profiles of major players in the industry.

SCOPE OF REPORT

This report offers forecasts, by product segment, from 2015 through 2020, including supporting analyses for projections. Product segments covered consist of the solid organ (e.g., kidneys, liver, heart-lung, pancreas, intestines) and the tissue transplantation (e.g., bone, skin, cornea, heart valve) markets, along with the pharmaceuticals that accompany each market.

Also included are experimental xenografts and artificial organs; tissue transplants; and cell transplants (e.g., bone marrow, cord blood, peripheral blood, islet cell). The report touches on the use of fetal cells, stem cells and altered cancer cells.

The arrangement of this report offers an overview of the key elements in the transplantation process: tissue typing, procurement and preservation, immunosuppressants for solid organ and tissue transplants and postoperative monitoring. International markets are discussed, and information is provided on industry structure and the regulatory environment.

Within each section are discussions of commercialization opportunities for each segment of the market. New or emerging devices, techniques and pharmaceuticals are highlighted.

Profiles of more than 50 leading companies involved with solid organ transplantation, tissue transplantation, and alternative technologies are included. The report provides information on company placement within the market and strategic analyses of the companies’ available and emerging products.

An appendix featuring various terms and processes used in transplantation is provided at the end of the report.

This report cites autologous products only in relation to their impact on the market for allografts. It does not include blood products, with the exception of peripheral and umbilical cord blood as a source of stem cells.

ANALYST’S CREDENTIALS

Peggy S. Lehr is the BCC Research analyst for this report. Ms. Lehr has worked with the publishing arms of for-profit and not-for-profit organizations for more than 25 years, and she specializes in marketing reports on the medical industry. She has contributed several reports on the medical industry for BCC, including reports on the global market for catheters, the sterilization market, reports on pediatric and eldercare markets, cardiovascular surgical industry and her most recent report on the global allergy diagnosis and treatment market.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com

Single User License 2-5 User License

[+] Show Chapter Details

Note: Reports are discounted or included with certain Memberships. See Membership Options.

	Title/Chapter Name	Pages	Price	Member Price
	Full Report: Organ and Tissue Transplantation and Alternatives	196	$2,750	Free
	Chapter- 1: Introduction	4		Free
REASONS FOR DOING THE STUDY STUDY GOALS AND OBJECTIVES SCOPE OF REPORT METHODOLOGIES AND INFORMATION SOURCES ANALYST'S CREDENTIALS RELATED BCC RESEARCH REPORTS BCC RESEARCH WEBSITE DISCLAIMER
	Chapter- 2: SUMMARY	4	$250	Free
COST OF CARE GLOBAL MARKET SOLID ORGAN PRESERVATION IMMUNOSUPPRESSION DONATION SOFT TISSUE MARKET ORGAN ALTERNATIVES GLOBAL MARKET PROJECTIONS
	Chapter- 3: INDUSTRY OVERVIEW	28	$393	Free
HISTORY OF TRANSPLANTATION INDUSTRY ACQUISITIONS NECESSARY COMPONENTS TO ORGAN AND TISSUE TRANSPLANTATION OVERVIEW OF THE DONATION PROCESS THE TRANSPLANTATION PROCESS SOLID ORGANS TISSUE TRANSPLANTATION IN THE U.S. TRANSPLANTATION TRENDS OUTSIDE THE U.S. TRENDS IN LIVING AND CADAVERIC DONATIONS OUTSIDE THE U.S. GLOBAL SOLID ORGAN TRANSPLANTATION LIMITED ORGAN SUPPLY CURTAILS TRANSPLANTATIONS KEY FACTORS IN INDUSTRY GROWTH KEY FACTORS INHIBITING GROWTH REGULATIONS AND REIMBURSEMENT REGULATIONS IN THE U.S. REGULATIONS OUTSIDE THE U.S. REIMBURSEMENT IN THE U.S. REIMBURSEMENT OUTSIDE THE U.S.
	Chapter- 4: TISSUE TYPING TECHNOLOGIES	6	$84	Free
ROLE OF TISSUE TYPING IN TRANSPLANTATION TISSUE TYPING TECHNOLOGIES HLA ANALYSIS METHODS GLOBAL TISSUE TYPING MARKET REGIONAL ANALYSIS
	Chapter- 5: SOLID ORGAN PROCUREMENT AND PRESERVATION	19	$267	Free
DEFINITION OF BRAIN DEATH ORGANS OBTAINED FOR TRANSPLANT INCREASING SUPPLY IN THE U.S. THE TRANSPLANT GROWTH AND MANAGEMENT COLLABORATIVE SUPPLY MANAGEMENT ORGAN PROCUREMENT OUTSIDE THE U.S. ALLOCATION CRITERIA IN THE U.S. ALLOCATION CRITERIA IN THE EU SOLID ORGAN PRESERVATION GLOBAL MARKET FOR ORGAN PRESERVATION METHODS MARKET FOR PRESERVATION SOLUTIONS GLOBAL MARKET SHARE OF ORGAN PRESERVATION SOLUTIONS MACHINE PERFUSION PRESERVATION SOLUTIONS IN DEVELOPMENT
	Chapter- 6: TISSUE PRODUCTS	24	$337	Free
GLOBAL TISSUE MARKET, BY REGION SOFT TISSUE REPAIR AND REPLACEMENT PROJECTED GLOBAL SOFT TISSUE MARKET, BY REGION HEART VALVES CORNEA BLOOD STEM CELLS THE ORTHOBIOLOGICS MARKET SKIN GRAFTS VASCULAR TISSUE TRANSPLANTATION Table 22 : PROJECTED GLOBAL TISSUE GRAFTING MARKET, BY TISSUE TYPE THROUGH 2020
	Chapter- 7: IMMUNOSUPPRESSANTS, ANTI-INFECTIVES AND POST-TRANSPLANT MONITORING	26	$365	Free
TOLERANCE OF TRANSPLANTED ORGANS COMMON ANTI-REJECTION DRUG PROTOCOLS TYPES OF IMMUNOSUPPRESSANTS CALCINEURIN INHIBITORS ANTI-PROLIFERATIVE AGENTS M-TOR INHIBITORS MONOCLONAL AND POLYCLONAL ANTIBODY PRODUCTS T-CELL COSTIMULATION BLOCKER TREATMENTS BY STAGE OF PROCEDURE MAINTENANCE THERAPY IMMUNOSUPPRESSANT USE IN PEDIATRIC TRANSPLANTATION ADVANCES IN POST-OPERATIVE DESENSITIZATION GLOBAL IMMUNOSUPPRESSANT MARKET ANTI-INFECTIVES AND POST-TRANSPLANT MONITORING IN ORGAN AND TISSUE TRANSPLANTATION
	Chapter- 8: ALTERNATIVE DEVICES AND TECHNOLOGIES	21	$295	Free
ALTERNATIVES TO HEART TRANSPLANTATION OPPORTUNITIES IN THE ORTHOPEDIC DEVICE MARKET MARKET LEADERS IN ORTHOPEDIC REPLACEMENTS HIP KNEE SPINE EXTREMITIES ALTERNATIVES TO CORNEAL TRANSPLANTATION ALTERNATIVES TO INTESTINAL TRANSPLANTATION ALTERNATIVES TO PANCREAS TRANSPLANTATION ALTERNATIVES TO LIVER TRANSPLANTATION ALTERNATIVES TO VASCULAR TRANSPLANTATION REGIONAL ANALYSIS Table 51 : PROJECTED GLOBAL MARKET FOR TRANSPLANTATION ALTERNATIVE DEVICES, THROUGH 2020
	Chapter- 9: EMERGING PROCEDURES AND PRODUCTS IN DEVELOPMENT	10	$140	Free
ORGAN PRESERVATION SOLUTIONS IN DEVELOPMENT REGENERATIVE MEDICINE STEM CELL RESEARCH ADVANCES IN CARDIOVASCULAR TREATMENTS IMMUNOSUPPRESSIVE AGENTS IN DEVELOPMENT PHARMACEUTICAL PIPELINE DEVELOPMENT EXTREMITY REPAIR/REPLACEMENT
	Chapter- 10: COMPANY DIRECTORY	51	$716	Free
TISSUE TYPING/DIAGNOSTICS PRESERVATION SOLUTIONS (SOLID ORGAN/CELL/TISSUE)/ TRANSPORT SYSTEMS TRANSPLANT PHARMACEUTICALS (IMMUNOSUPPRESSANTS, POST-TRANSPLANT PHARMACEUTICALS) MECHANICAL HEART IMPLANTS HEART VALVES JOINT/ORTHOPEDIC IMPLANTS TISSUE/BONE REGENERATIVE PRODUCTS
	Chapter- 11: APPENDIX	3	$42	Free
Table 67 : DEFINITIONS

Published - Jan-2011| Analyst - Peggy Lehr| Code - HLC012E

Report Highlights

The global market for transplantation products, devices, and pharmaceuticals was valued at nearly $54 billion in 2010 and is projected to grow at an 8.3% compound annual growth rate (CAGR) to reach $80 billion in 2015.

Published - Oct-2008| Analyst - Vicki McConnell| Code - HLC012D

Report Highlights

The U.S. market for organ and tissue transplantation and alternatives was worth $18.9 billion in 2007. The market is projected to grow to $20.9 billion in 2008 and $28.2 billion in 2013, representing a compound annual growth rate (CAGR) of 6.1%.
The solid organ segment has the largest share of the market, worth $9.7 billion in 2007 and an estimated $10.5 billion in 2008. This is expected to grow at a CAGR of 5.7% to reach $13.8 billion in 2013.
Tissue transplantation generated $9.2 billion in 2007. This should increase to $10.4 billion in 2008 and $14.3 billion in 2013, for a CAGR of 6.5%.

Published - Oct-2005| Analyst - Lynn Gray| Code - HLC012C

Report Highlights

The organ and tissue transplantation market in the U.S. is estimated at $11.7 billion in 2005 ad is expected to rise at an average annual growth rate (AAGR) of 5.2% to $15.1 billion by 2010.
The transplantation market is estimated at just under $5 billion in 2005 and is expanding at an AAGR of 4.8%.
The fastest growing sector is small bowel (intestine) transplantation. Kidney and liver transplantation will account for 78% of the total in 2005.
The U.S. tissue transplantation market totaled about $6.8 billion in 2005. It is projected to grow at an AAGR of 5.5%, to $8.9 billion in 2010.

Published - Mar-2003| Analyst - Peter Downs| Code - HLC012B

Report Highlights

Tissue and organ transplantation in the U.S. was a $17.3 billion market in 2002.
This is expected to grow 18% to $20.5 billion by 2007 at an average annual rate (AAGR) of 3.5%.
The fastest growing sector is small bowel transplantation.
Kidney transplantation accounted for 59% of U.S. organ transplants in 2002.